NEW YORK After hearing that the U.S. Court of Appeals for the Federal Circuit denied the emergency motion filed by Novartis regarding its Famvir medication, Teva has begun launching its generic version, Famciclovir tablets in 125, 250, and 500 mgs.
Novartis following a U.S. District Court in New Jersey’s preliminary injunction in favor of Teva filed the emergency motion to block sales of the drug. While Novartis appeals this decision, the Court of Appeals has decided to allow Teva to manufacture a generic, by refusing to order a sales halt while Novartis appeals the decision. The drug is used for the treatment of shingles and genital herpes.
Famvir had sales of $200 million for the 12 months ending June 30, 2007.